Devyser enters agreement with Thermo Fisher Scientific for commercialization of Devyser’s post-transplant NGS products
· Collaboration and distribution agreement with Thermo Fisher Scientific. · Thermo Fisher Scientific obtains exclusive rights to commercialize Devyser’s post-transplant monitoring portfolio in North America and Europe. Devyser Diagnostics AB (publ) today announced that the company has signed an exclusive collaboration and distribution agreement with Thermo Fisher Scientific. The agreement gives Thermo Fisher exclusive rights to commercialize, under combined brands, Devyser’s post-transplant portfolio of NGS products in North America and Europe.“Partnering with Thermo Fisher, the